Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OECD Guideline 412 (Repeated Dose Inhalation Toxicity: 28/14-Day)
Deviations:
yes
Remarks:
Dosing until day 5 only
GLP compliance:
yes (incl. QA statement)
Test type:
other: subacute
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium dihydrogen ethylenediaminetetraacetate
EC Number:
205-358-3
EC Name:
Disodium dihydrogen ethylenediaminetetraacetate
Cas Number:
139-33-3
Molecular formula:
C10H14N2Na2O8
IUPAC Name:
disodium dihydrogen 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Test material form:
solid
Specific details on test material used for the study:
Batch Number: 06088797V0
Expiry date: 01 September 2011

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 7 weeks (approx)
- Housing: housed together (5 animals per cage) in Polysulfon cages:Type Lignocel fibres, dust free bedding; Wooden gnawing blocks for enrichment

ENVIRONMENTAL CONDITIONS
Rooms: fully ariconditioned
- Temperature (°C): 20 to 24°C
- Humidity (%): 30-70%
- Photoperiod (hrs dark / hrs light): cycle of 12 hours (6 am to 6pm light, 6pm to 6 am dark)

Identification: Tattooing of ears
All animals free of disease and clinical signs. Food, drinking water and bedding/enrichment materials were analysed
for chemical and microbiological contaminants.

Administration / exposure

Route of administration:
inhalation: aerosol
Type of inhalation exposure:
nose/head only
Vehicle:
air
Details on inhalation exposure:
A dust aerosol was generated using a dust generator and compressed air inside a mixing stage mixed with conditioned dilution air and passed into the inhalation system. The test substance was mixed with Aerosil R972 prior to facilitate aerosol generation.
Analytical verification of test atmosphere concentrations:
yes
Remarks:
Concentrations of the inhalation atmospheres were analyzed using gravimetry. Daily means were calculated based on 2 measured samples per concentration and exposure. From the Daily mean values of each concentration, mean concentrations and standard deviati
Duration of exposure:
6 h
Remarks on duration:
per day, 5 consecutive days
Concentrations:
- 30, 300, 1000 mg/m³ (nominal conc. of Na2H2EDTA)
- 33.3 (+/-2.3), 320 (+/-27), 1103 (+/-52) mg/m3 (measured (with SD) referring to test substance Na2H2EDTA x 2 H2O)
No. of animals per sex per dose:
10 animals per dose group
An additional 10 animals for the high dose group and control
Control animals:
yes
Details on study design:
The animals were exposed to a respirable dust aerosol for 6 hours per day for 5 consecutive days. The exception was the high dose group (1000mg/m3) where exposure was for one day only due to mortality observed.
Statistics:
Body weight/body weight change, food consumption - comparison of each group with control using DUNNETTS test (two-sided) for the hypothesis of equal means
Clinical pathology, urine volumes, urine specific gravity, Weight parameters - Non-parametric one-way analysis using Kruskal-wallis test (two sided). If resulting p-value was less than 0.05, a pairwise comparison of each dose group with the control group was performed using Wilcoxon-test (two sided) for equal means.

Results and discussion

Effect levels
Key result
Sex:
male
Dose descriptor:
other: LOAEC
Effect level:
ca. 30 mg/m³ air
Based on:
act. ingr.
Remarks:
Na2H2EDTA
Remarks on result:
other: Basis for effect level: histopathology of the respiratory tract and lung weights
Mortality:
6 deaths in the high dose group on days 0 and 1. Accelerated respiration, respiration sounds, piloerection, red encrusted nose, hunched position; Mid dose group - accelerated respiration, respiration sounds, piloerection, reduced fur care
Clinical signs:
other: 6 deaths in the high dose group on days 0 and 1. Accelerated respiration, respiration sounds, piloerection, red encrusted nose, hunched position; Mid dose group - accelerated respiration, respiration sounds, piloerection, reduced fur care
Body weight:
Decreased bodyweight change in mid and high dose group
Gross pathology:
Congestion, edema and multifocal hemorraghes in lungs of high dose group
Other findings:
FOOD CONSUMPTION
- decreased food consumption between days 0 and 1 in mid and high dose group

ORGAN WEIGHTS
- Lung weight increase in low and mid dose group

HISTOPATHOLOGY
High dose: Multifocal hemorraghes in the lungs; inflammatory cell infiltrates
Mid dose:
- Larynx: laryngeal, epithelial necrosis, multifocal, in various levels of the larynx; inflammatory cell infiltrates in various levels of the larynx laryngeal squamous metaplasia, multifocal, in various levels of the larynx; regenerative hyperplasia of the laryngeal epithelium, multifocal, in various levels of the larynx
- Lungs: Regenerative hyperplasia of bronchiolar epithelium (predominantly: medium bronchi, terminal bronchioles), mucous cell hyperplasia in large bronchi, interstitial infiltration of eosinophylic granulocytic cells
Low dose:
- Larynx: Laryngeal, epithelial necrosis, multifocal, at the base of the epiglittis (level 1), Inflammatory cell infiltrates at the base of the epiglottis (level 1)
- Lungs: Regenerative hyperplasia of the bronchiolar epithelium (predominantly medium bronchi and terminal bronchioles), mucous cell hyperplasia in large bronchi, interstitial infiltration of eosinophylic granulocytic cells
There were no histopathological findings in any of the recovery group animals. Thus all pathology was reversible within the recovery period.

Applicant's summary and conclusion